Atherosclerosis (journal)

Atherosclerosis is a medical journal that focuses on the study of atherosclerosis, a disease in which plaque builds up inside your arteries. The journal publishes original research articles, reviews, and editorials on all aspects of atherosclerosis, including its pathogenesis, epidemiology, clinical diagnosis, treatment, and prevention.

Overview

The Atherosclerosis journal was first published in 1969 and is currently published by Elsevier. The journal is affiliated with the European Atherosclerosis Society and the International Atherosclerosis Society. It is indexed in the PubMed database and the Science Citation Index. The journal's impact factor for 2019 was 4.25.

Scope

The Atherosclerosis journal covers a wide range of topics related to atherosclerosis. These include, but are not limited to, the molecular biology of atherosclerosis, genetic and environmental risk factors, the role of lipids and lipoproteins, inflammation, immunology, cell biology, pharmacology, endocrinology, nutrition, surgery, and cardiology.

Editorial Board

The Atherosclerosis journal's editorial board is composed of leading experts in the field of atherosclerosis from around the world. The current editor-in-chief is Professor John J.P. Kastelein from the University of Amsterdam, The Netherlands.

Submission and Review Process

The Atherosclerosis journal follows a rigorous peer review process to ensure the quality and integrity of the research it publishes. Authors are encouraged to submit their manuscripts online through the journal's submission system. The submitted manuscripts are then reviewed by at least two independent reviewers who are experts in the field.

Access

The Atherosclerosis journal offers both subscription-based and open access options for readers. The journal's content is available online through the publisher's website and other digital platforms.